Petros pharmaceuticals announces $7.5 million offering

New york, dec. 22, 2021 /prnewswire/ -- petros pharmaceuticals, inc. (nasdaq: ptpi), a leading provider of therapeutics for men's health, today announced that it has entered into definitive agreements with the company's largest investor and other existing investors, for the purchase and sale of 2,186,589 shares of petros pharmaceuticals' common stock, at a purchase price of $3.43 per share. the company will sell 1,545,183 shares in a registered direct offering and the remaining 641,406 shares will be sold in a private placement.
PTPI Ratings Summary
PTPI Quant Ranking